Price target
98.650.000.00%
The 2 analysts offering 1 year price forecasts for DRUG have a max estimate of — and a min estimate of —.
Analyst rating
Based on 3 analysts giving stock ratings to DRUG in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
DRUG EPS for the last quarter is −0.18 CAD despite the estimation of −0.60 CAD. In the next quarter EPS is expected to reach −0.50 CAD. Track more of BRIGHT MINDS BIOSCIENCES INC. financials and stay on top of what is up with the company.
In the next quarter BRIGHT MINDS BIOSCIENCES INC. revenue is expected to reach 0.00 CAD. Check out BRIGHT MINDS BIOSCIENCES INC. revenue and earnings and make informed decisions.
According to analysts, DRUG price target is 98.65 CAD with a max estimate of 122.30 CAD and a min estimate of 75.00 CAD. Check if this forecast comes true in a year, meanwhile watch BRIGHT MINDS BIOSCIENCES INC. stock price chart and keep track of the current situation with DRUG news and stock market news.